Dr. Schuster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3 Edmund D Pellegrino Rd
Stony Brook, NY 11794Phone+1 631-444-3577Fax+1 631-444-2112- Is this information wrong?
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1987
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1980 - 1983
- Geisel School of Medicine at DartmouthClass of 1980
Certifications & Licensure
- CA State Medical License 1981 - Present
- MA State Medical License 1982 - 2025
- NY State Medical License 1987 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Newsday - Top Doctors on Long Island Castle Connolly, 2011-2020
- America's Top Doctors for Cancer Castle Connolly, 2005-2020
- Top Doctors: New York Metro Area Castle Connolly, 2003-2014, 2016-2020
- Join now to see all
Clinical Trials
- Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients Start of enrollment: 2010 Jun 01
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib Start of enrollment: 2010 Nov 01
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsA phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes.Sekeres, M., Schuster, M., Joris, M., Krauter, J., Maertens, J., Breems, D., Gyan, E., Kovacsovics, T., Verma, A., Vyas, P., Wang, E., Ching, K., O'Brien, T., Gallo St...> ;Annals of Hematology. 2022 Aug 1
- 1 citationsThe Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.Josée M Zijlstra, George Follows, Rene-Olivier Casasnovas, Joost S P Vermaat, Nagesh Kalakonda, Sylvain Choquet, Brian Hill, Catherine Thieblemont, Federica Cavallo, F...> ;Cancers. 2022 Feb 4
- 1 citationsEffect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Anal...Michael Schuster, Josée Zijlstra, Rene-Olivier Casasnovas, Joost S P Vermaat, Nagesh Kalakonda, Andre Goy, Sylvain Choquet, Eric Van Den Neste, Brian Hill, Catherine T...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Jul 1
- Join now to see all
Abstracts/Posters
- A Phase 1b Study of Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Mye...Michael W. Schuster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Clinical Benefit of Glasdegib in Combination with Azacitidine or Low-Dose Cytarabine in Patients with Acute Myeloid LeukemiaClinically Relevant AbstractMichael W. Schuster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
- Member
Hospital Affiliations
- Stony Brook University HospitalStony Brook, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: